Informaçao sobre o Autor

KRAVCHENKO, A. V

Edição	Seção	Título	Arquivo
Nº 4 (2012)	Articles	HIV AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASES
Nº 2 (2013)	Articles	ROLE OF RISK FACTORS IN THE DEVELOPMENT OF CARDIOVASCULAR DISEASE IN HIV-INFECTED PATIENTS WITH THE NATURAL HISTORY OF HIV INFECTION
Nº 4 (2013)	Articles	GENDER FEATURES OF THE DEVELOPMENT OF CARDIOVASCULAR RISKS IN HIV-INFECTED PATIENTS NOT RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
Nº 6 (2014)	Articles	DUAL ANTIRETROVIRAL THERAPY WITH LOPINAVIR AND RITONAVIR
Nº 1 (2015)	Articles	Hepatotoxicity of antiretroviral therapy in HIV-infected patients
Nº 5 (2015)	Articles	The efficacy and safety of a new Russian HIV non-nucleoside reverse transcriptase inhibitor (VM-1500, Elpivirine) as a component in an antiretroviral therapy regimen
Nº 6 (2015)	Articles	HIV drug resistance: Dolutegravir is a second-generation HIV integrase inhibitor
Nº 3 (2016)	Articles	Genetic markers for HIV infection progression and secondary diseases development
Nº 5 (2016)	Articles	The efficacy and safety of Elpivirine as part of a 24-48-week antiretroviral therapy regimen versus an Efavirenz-containing regimen
Nº 1 (2011)	Articles	MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME DURING ANTIRETROVIRAL THERAPY IN PATIENTS WITH HIV INFECTION
Nº 2 (2011)	Articles	THE HIV NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS ABACAVIR AND LAMIVUDINE IN FIRST-LINE ANTIRETROVIRAL THERAPY REGIMENS
Nº 3 (2018)	Articles	Bacterial excretion in patients with HIV infection and tuberculosis